Cargando…

Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center

OBJECTIVES: To determine the feasibility of using real-world data to assess the safety and effectiveness of two cardiac ablation catheters for the treatment of persistent atrial fibrillation and ischaemic ventricular tachycardia. DESIGN: Retrospective cohort. SETTING: Three health systems in the USA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhruva, Sanket S, Jiang, Guoqian, Doshi, Amit A, Friedman, Daniel J, Brandt, Eric, Chen, Jiajing, Akar, Joseph G, Ross, Joseph S, Ervin, Keondae R, Collison Farr, Kimberly, Shah, Nilay D, Coplan, Paul, Noseworthy, Peter A., Zhang, Shumin, Forsyth, Thomas, Schulz, Wade L, Yu, Yue, Drozda, Jr., Joseph P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749235/ https://www.ncbi.nlm.nih.gov/pubmed/35047806 http://dx.doi.org/10.1136/bmjsit-2021-000089

Ejemplares similares

Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice
por: Dhruva, Sanket S., et al.
Publicado: (2022)

Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation
por: Yu, Yue, et al.
Publicado: (2023)

Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report
por: Jiang, Guoqian, et al.
Publicado: (2021)

Catheter-related complications and mortality of atrial fibrillation ablation following introduction of contact force-sensing technology
por: Akar, Joseph G, et al.
Publicado: (2020)

Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices
por: Bartlett, Victoria L., et al.
Publicado: (2021)

Heart Watch Study: protocol for a pragmatic randomised controlled trial
por: Dhruva, Sanket S, et al.
Publicado: (2021)

Exploring unique device identifier implementation and use for real-world evidence: a mixed-methods study with NESTcc health system network collaborators
por: Dhruva, Sanket S., et al.
Publicado: (2023)

Aggregating multiple real-world data sources using a patient-centered health-data-sharing platform
por: Dhruva, Sanket S., et al.
Publicado: (2020)

Evolution of the American College of Cardiology and American Heart Association Cardiology Clinical Practice Guidelines: A 10‐Year Assessment
por: DuBose‐Briski, Victoria, et al.
Publicado: (2019)

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
por: Liu, Patrick, et al.
Publicado: (2021)

Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
por: Bartlett, Victoria L., et al.
Publicado: (2019)

Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks
por: Lu, Yuan, et al.
Publicado: (2023)

Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
por: Bartlett, Victoria L., et al.
Publicado: (2020)

Evidence supporting FDA approval and CMS national coverage determinations for novel medical products, 2005 through 2016: A cross-sectional study
por: Roginiel, Aliya C., et al.
Publicado: (2018)

Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval
por: Shaw, Daniel L., et al.
Publicado: (2018)

PreScription DigitaL ThErapEutic for Patients with Insomnia (SLEEP-I): a protocol for a pragmatic randomised controlled trial
por: Dreyer, Rachel P, et al.
Publicado: (2022)

Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
por: Mooghali, Maryam, et al.
Publicado: (2023)

Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
por: Wallach, Joshua D., et al.
Publicado: (2021)

Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
por: Deng, Yihong, et al.
Publicado: (2022)

Use of Mechanical Cardiopulmonary Resuscitation Devices for Out-of-Hospital Cardiac Arrest, 2010-2016
por: Kahn, Peter A., et al.
Publicado: (2019)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
por: Wallach, Joshua D., et al.
Publicado: (2021)

Medical device risk (re)classification: lessons from the FDA’s 515 Program Initiative
por: Mooghali, Maryam, et al.
Publicado: (2023)

GLASS(Y) Half-Full: Moving Towards Greater Pragmatism in Outcome Ascertainment for Clinical Trials
por: Dhruva, Sanket S.
Publicado: (2021)

Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
por: Wallach, Joshua D., et al.
Publicado: (2019)

Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Accurate estimation of cardiovascular risk in a non-diabetic adult: detecting and correcting the error in the reported Framingham Risk Score for the Systolic Blood Pressure Intervention Trial population
por: Warner, Frederick, et al.
Publicado: (2018)

Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
por: Essa, Mohammed, et al.
Publicado: (2023)

Observations on the Catheter
por: M'Sweeny, Joseph
Publicado: (1819)

Medical Device Regulation: Time to Improve Performance
por: Dhruva, Sanket S., et al.
Publicado: (2012)

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
por: Fleischman, William, et al.
Publicado: (2019)

How real-world evidence can really deliver: a case study of data source development and use
por: Drozda, Joseph, et al.
Publicado: (2020)

Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study
por: Liu, Patrick, et al.
Publicado: (2019)

Seeking clarity on retinal findings in patients with COVID-19
por: Collison, Frederick T, et al.
Publicado: (2020)

Systematic in vivo evaluation of the time-dependent inflammatory response to steel and Teflon insulin infusion catheters
por: Hauzenberger, Jasmin R., et al.
Publicado: (2018)

Advancing Patient Safety Surrounding Medical Devices: Barriers, Strategies, and Next Steps in Health System Implementation of Unique Device Identifiers
por: Wilson, Natalia A, et al.
Publicado: (2022)

A multicenter evaluation of computable phenotyping approaches for SARS-CoV-2 infection and COVID-19 hospitalizations
por: Khera, Rohan, et al.
Publicado: (2022)

Multi-institutional distributed data networks for real-world evidence about medical devices: building unique device identifiers into longitudinal data (BUILD)
por: Drozda, Joseph P, et al.
Publicado: (2022)

The coordination chemistry and magnetism of some 3d–4f and 4f amino-polyalcohol compounds
por: Sharples, Joseph W., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a0s7ckkrcqkcjnsgdcafetdk2q